Ganlai's FXR agonist ASC42 completes first patient dosing in US Phase I clinical trial New drug for cystic fibrosis! EC approves Sym ...

heroes of might and magic ps5 Vertex's Kalydeco for cystic fibrosis is close to approval in the EU 『Pharmaceutical Headlines』Two batches of injections were recalled due to cross contamination Zhejiang ...

INR:3725. across the unlverse fiona apple Will the next round of centralized procurement include Caronin, Enbipu, and Shupushen? "Fake stock" ST K ...

INR:6853. best online casino sign up bonus Science: Revealing the structure of hinge-like protein provides new ideas for treating cystic fibrosis ...

ban ipl New drug for cystic fibrosis! EC approves Symkevi combined with Kalydeco for children aged 6-11 years Small molecule drug conjugates: Can the legendary story continue? The first plant-derived ...

INR:6273. lakshmi lottery GSK's two-drug HIV therapy to receive priority review The first peanut allergy immunotherapy! Aimmune's desensitization therapy Palforzi ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...

In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...

A $42,000 grant from NASA and INBRE will further CF research, through a collaborative effort spanning to India and the United Kingdom.

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...

Changing Futures, a nonprofit dedicated to advancing cystic fibrosis (CF) research, will hold a polar plunge at noon New Year ...